UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.;ABBVIE INC.
发明人:
NIELSEN, Soren,JONASSEN, Thomas Engelbrecht, Nordkild,KHAN, Samina,HOUSER, Mark, T.,LUMHOLTZ, Ib, Bo,BECKERT, Michael,BEAVER, Thomas
申请号：
USUS2013/063698
公开号：
WO2014/058786A2
申请日:
2013.10.07
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to a dosage regime of a peptide analogues of [alpha]-melanocyte-stimulating hormone ([alpha]-MSH), which possesses an increased efficacy compared to the native [alpha]-MSH peptide in the treatment or prevention of kidney injury or disease.
